BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND RUNX1T1, ENSG00000079102, 862 AND Treatment
34 results:

  • 1. A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy.
    Wang P; Chen K; Wang J; Ni Z; Shang N; Meng W
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):9757-9765. PubMed ID: 37247082
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
    Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
    Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictors of Secondary Lung Cancer Among Hodgkin lymphoma Survivors: A Nationwide Analysis.
    Alnimer Y; Ali MKM
    Clin Lung Cancer; 2022 Dec; 23(8):e510-e518. PubMed ID: 36008241
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinicopathologic Characteristics Associated with Prognosis in Ocular Extranodal Marginal Zone B Cell lymphoma.
    Choi S; Seo M; Park SH; Jo JC; Chae SW; Lee JH; Cha HJ
    Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744081
    [No Abstract]    [Full Text] [Related]  

  • 5. Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis.
    Zhang W; Jang E
    PLoS One; 2021; 16(8):e0256801. PubMed ID: 34437635
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological Evaluation of Acute Leukemias in a Tertiary Care Hospital: A Cross-Sectional Study.
    Patel GN; Gudur R; Gudur A; Oswal RM; Kanethkar S
    Turk Patoloji Derg; 2021; 37(2):145-153. PubMed ID: 33973643
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
    Shouval R; Fein JA; Labopin M; Cho C; Bazarbachi A; Baron F; Bug G; Ciceri F; Corbacioglu S; Galimard JE; Giebel S; Gilleece MH; Giralt S; Jakubowski A; Montoto S; O'Reilly RJ; Papadopoulos EB; Peric Z; Ruggeri A; Sanz J; Sauter CS; Savani BN; Schmid C; Spyridonidis A; Tamari R; Versluis J; Yakoub-Agha I; Perales MA; Mohty M; Nagler A
    Lancet Haematol; 2021 Mar; 8(3):e205-e215. PubMed ID: 33636142
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia.
    Gottschalk Højfeldt S; Grell K; Abrahamsson J; Lund B; Vettenranta K; Jónsson ÓG; Frandsen TL; Wolthers BO; Marquart HV; Vaitkeviciene G; Lepik K; Heyman M; Schmiegelow K; Albertsen BK
    Blood; 2021 Apr; 137(17):2373-2382. PubMed ID: 33150360
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Puangpetch A; Tiyasirichokchai R; Pakakasama S; Wiwattanakul S; Anurathapan U; Hongeng S; Sukasem C
    Pharmacogenomics; 2020 Apr; 21(6):403-410. PubMed ID: 32308129
    [No Abstract]    [Full Text] [Related]  

  • 10. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
    Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The clinical mutatome of core binding factor leukemia.
    Opatz S; Bamopoulos SA; Metzeler KH; Herold T; Ksienzyk B; Bräundl K; Tschuri S; Vosberg S; Konstandin NP; Wang C; Hartmann L; Graf A; Krebs S; Blum H; Schneider S; Thiede C; Middeke JM; Stölzel F; Röllig C; Schetelig J; Ehninger G; Krämer A; Braess J; Görlich D; Sauerland MC; Berdel WE; Wörmann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
    Leukemia; 2020 Jun; 34(6):1553-1562. PubMed ID: 31896782
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gonadal Function Recovery and Fertility in Women Treated with Chemo- and/or Radiotherapy for Hodgkin's and Non-Hodgkin lymphoma.
    Gini G; Annibali O; Lupasco D; Bocci C; Tomarchio V; Sampaolo M; Trappolini S; Tafuri MA; Cacciagiù S; Ciccarone M; Barucca A; Sarlo C; Vincenzi B; Avvisati G; Leoni P; Olivieri A
    Chemotherapy; 2019; 64(1):36-41. PubMed ID: 31117081
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
    Janikova A; Chloupkova R; Campr V; Klener P; Hamouzova J; Belada D; Prochazka V; Pytlik R; Pirnos J; Duras J; Mocikova H; Bortlicek Z; Kopalova N; Mayer J; Trneny M
    Ann Hematol; 2019 Aug; 98(8):1961-1972. PubMed ID: 31065733
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Risk factors for Burkitt lymphoma in East African children and minors: A case-control study in malaria-endemic regions in Uganda, Tanzania and Kenya.
    Peprah S; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Sumba PO; Masalu N; Kawira E; Magatti J; Kinyera T; Otim I; Legason ID; Nabalende H; Dhudha H; Ally H; Genga IO; Mumia M; Ayers LW; Pfeiffer RM; Biggar RJ; Bhatia K; Goedert JJ; Mbulaiteye SM
    Int J Cancer; 2020 Feb; 146(4):953-969. PubMed ID: 31054214
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature.
    Assaf N; El-Cheikh J; Bazarbachi A; Salem Z; Farra C; Chakhachiro Z; Nassif S; Zaatari G; Mahfouz R
    Mol Biol Rep; 2019 Apr; 46(2):2003-2011. PubMed ID: 30701458
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A Generic Model for Follicular lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
    Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
    Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.
    Jeong SH; Song HN; Park JS; Yang DH; Koh Y; Yoon SS; Lee HW; Eom HS; Won JH; Kim WS; Kim SJ
    Biol Blood Marrow Transplant; 2018 Dec; 24(12):2471-2478. PubMed ID: 30064012
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
    Dührsen U; Müller S; Hertenstein B; Thomssen H; Kotzerke J; Mesters R; Berdel WE; Franzius C; Kroschinsky F; Weckesser M; Kofahl-Krause D; Bengel FM; Dürig J; Matschke J; Schmitz C; Pöppel T; Ose C; Brinkmann M; La Rosée P; Freesmeyer M; Hertel A; Höffkes HG; Behringer D; Prange-Krex G; Wilop S; Krohn T; Holzinger J; Griesshammer M; Giagounidis A; Raghavachar A; Maschmeyer G; Brink I; Bernhard H; Haberkorn U; Gaska T; Kurch L; van Assema DME; Klapper W; Hoelzer D; Geworski L; Jöckel KH; Scherag A; Bockisch A; Rekowski J; Hüttmann A;
    J Clin Oncol; 2018 Jul; 36(20):2024-2034. PubMed ID: 29750632
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
    Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G
    Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A minicircuitry of microRNA-9-1 and RUNX1-runx1t1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia.
    Fu L; Shi J; Liu A; Zhou L; Jiang M; Fu H; Xu K; Li D; Deng A; Zhang Q; Pang Y; Guo Y; Hu K; Zhou J; Wang Y; Huang W; Jing Y; Dou L; Wang L; Xu K; Ke X; Nervi C; Li Y; Yu L
    Int J Cancer; 2017 Feb; 140(3):653-661. PubMed ID: 27770540
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.